Delivery Order SPE2DB22D3301-SPE2DB25FY9TX
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units. This contract, valued at $2,631.62, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units) with a ceiling value of $6,742.70 and a completion date of August 19, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $5,359.73. This non-competitive delivery order is set to be completed by August 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,346.88 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's broader indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count packaging) with a ceiling value of $1,650.08 under a firm fixed price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a $1,996.61 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's typical federal procurement profile....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count package) valued at $30,553.34 under a firm fixed-price delivery order with no set-aside designation. The contract is scheduled for ultimate completion on August 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $8,325.99 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9TXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Entacapone 200 mg tablets (100-count units) at a ceiling value of $1,097.95. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of medications and medical supplies to support military and federal healthcare systems globally. The Entacapone supply fulfills the company's role in distributing neurological and therapeutic medications to military personnel and Veterans Health Administration beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/20/25 |